Citadel Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20,100
| Closed | -$4.23K | – | 15486 |
|
|
2023
Q2 | $4.23K | Hold |
20,100
| – | – | ﹤0.01% | 13616 |
|
|
2023
Q1 | $3.22K | Buy |
+20,100
| New | +$8.93K | ﹤0.01% | 14060 |
|
|
2022
Q1 | – | Sell |
-19,100
| Closed | -$43K | – | 14962 |
|
|
2021
Q4 | $43K | Sell |
19,100
-9,200
| -33% | -$23.1K | ﹤0.01% | 13329 |
|
|
2021
Q3 | $97K | Buy |
28,300
+5,500
| +24% | +$17K | ﹤0.01% | 12919 |
|
|
2021
Q2 | $68K | Sell |
22,800
-5,600
| -20% | -$17.7K | ﹤0.01% | 13184 |
|
|
2021
Q1 | $92K | Buy |
28,400
+16,200
| +133% | +$54K | ﹤0.01% | 12544 |
|
|
2020
Q4 | $26K | Buy |
+12,200
| New | +$20.1K | ﹤0.01% | 10739 |
|
|
2018
Q3 | – | Sell |
-13,000
| Closed | -$25K | – | 9846 |
|
|
2018
Q2 | $25K | Buy |
13,000
+2,200
| +20% | +$4.45K | ﹤0.01% | 8600 |
|
|
2018
Q1 | $23K | Buy |
+10,800
| New | +$23.2K | ﹤0.01% | 8103 |
|
|
2017
Q1 | – | Sell |
-16,300
| Closed | -$22K | – | 8198 |
|
|
2016
Q4 | $22K | Buy |
+16,300
| New | +$21.3K | ﹤0.01% | 7061 |
|
|
2015
Q4 | – | Sell |
-2,400
| Closed | -$20K | – | 9343 |
|
|
2015
Q3 | $20K | Sell |
2,400
-1,100
| -31% | -$10.1K | ﹤0.01% | 8156 |
|
|
2015
Q2 | $38K | Sell |
3,500
-15,600
| -82% | -$200K | ﹤0.01% | 7842 |
|
|
2015
Q1 | $267K | Buy |
19,100
+5,100
| +36% | +$78K | ﹤0.01% | 5822 |
|
|
2014
Q4 | $236K | Sell |
14,000
-4,700
| -25% | -$68.4K | ﹤0.01% | 5777 |
|
|
2014
Q3 | $251K | Buy |
18,700
+16,200
| +648% | +$193K | ﹤0.01% | 5474 |
|
|
2014
Q2 | $32K | Sell |
2,500
-600
| -19% | -$6.25K | ﹤0.01% | 7046 |
|
|
2014
Q1 | $37K | Sell |
3,100
-4,400
| -59% | -$59K | ﹤0.01% | 6966 |
|
|
2013
Q4 | $104K | Sell |
7,500
-16,100
| -68% | -$227K | ﹤0.01% | 5576 |
|
|
2013
Q3 | $412K | Sell |
23,600
-48,800
| -67% | -$935K | ﹤0.01% | 4019 |
|
|
2013
Q2 | $1.18M | Buy |
+72,400
| New | +$2.24M | ﹤0.01% | 3024 |
|
Other funds holding INFI
Citadel Advisors's INFI Position: Q2 2023 in Review
Citadel Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2023, closing a stake of 393,296 shares — an estimated $68.3K sold.
Citadel Advisors first reported a position in INFI in Q2 2013 and held it in 28 quarters. The position peaked at $7.57M in Q4 2014. 45 funds tracked by Wall St. Rank hold INFI as of Q2 2023.
- Citadel Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
- Citadel Advisors sold 393,296 Infinity Pharmaceuticals, Inc. shares in Q2 2023, an estimated $68.3K.
- Citadel Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 28 quarters.
- Citadel Advisors's Infinity Pharmaceuticals, Inc. position peaked at $7.57M in Q4 2014.
- 45 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2023.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.